16家医院ICU病原学送检多环节优化干预对抗菌药物使用、临床结局与费用的影响
Impact of optimized intervention to multi-link processes of etiological submissionon use of antibiotics, clinical outcomes and costs in ICUs of 16 hospitals
-
摘要: 目的 通过优化16家医院重症监护病房(ICU)病原学送检关键环节,评估其对送检率、送检质量、抗菌药物使用、患者临床结局及医疗费用所产生的综合影响。方法 采用多阶段分层目的性抽样,选取16家医院ICU为研究对象,按时间划分为对照期(2023年1-11月)与干预期(2024年1-11月)。干预措施涵盖送检管理机制完善、检验报告流程优化、检验质量提升及信息系统建设等综合策略,通过比较干预前后主要指标变化,并构建混合线性模型,分析送检环节优化对抗菌药物使用、临床结局及医疗费用的影响。结果 干预后,ICU抗菌药物治疗前指向性病原学送检率提升(74.72% vs. 86.01%),血培养检验前周转时间缩短(0.50 h vs. 0.26 h),痰标本合格率(80.82% vs. 87.18%)、血培养双侧双套占比(77.33% vs. 94.64%)及血培养阳性率(18.75% vs. 23.84%)均提高,人均抗菌药物费用(6.46千元 vs. 4.55千元)下降(均P<0.05)。关联分析显示:缩短检验前周转时间、提高无菌标本送检比例和抗菌药物使用强度降低相关; 提高痰标本合格率、血培养双侧双套占比与人均抗菌药物费用及住院总费用的减少相关。此外,提高无菌标本送检比例与病死率降低相关(均P<0.05)。结论 病原学送检多环节优化干预,能有效改善ICU病原学送检质量与效率,指导抗菌药物精准使用,降低医疗费用,并对患者预后产生积极影响。Abstract: OBJECTIVE To observe the compressive effect of the optimization of key links of etiological submission on the submission rate, submission quality, use of antibiotics, clinical treatment outcomes and medical costs in ICUs of 16 hospitals. METHODS A multi-stage stratified purposive sampling method was employed to select the intensive care units (ICUs) of 16 hospitals as the research subjects, which were divided into the control phase (January to November 2023) and the intervention phase (January to November 2024) according to the study period. The intervention comprised comprehensive strategies, including optimizing the specimen submission management mechanism, optimizing laboratory reporting workflows, enhancing testing quality, and developing information systems. The changes in key indicators were observed and compared before and after the intervention, and a mixed linear model was constructed to analyze the impact of optimizing the specimen submission process on use of antibiotics, clinical outcomes, and medical costs. RESULTS The targeted etiological submission rate prior to antimicrobial therapy in ICUs was 86.01% after the intervention, higher than 74.72% before the intervention. The pre-analytical turnaround time (TAT) for blood cultures was 0.26 hour after the intervention, shorter than 0.50 hour before the intervention; the qualified rate of sputum specimens was 87.18% after the intervention, higher than 80.82% before the intervention; the proportion of bilateral dual-set blood cultures was 94.64% after the intervention, higher than 77.33% before the intervention; the positive rate of blood culture was 23.84% after the intervention, higher than 18.75% before the intervention; the per capita cost of antimicrobial agents was 4 550 yuan after the intervention, less than 6 460 yuan before the intervention(all P<0.05). Correlation analysis revealed that the shorter pre-analytical TAT and higher proportion of sterile specimen submissions were associated with the reduced antimicrobial use density; the higher qualified rate of sputum specimens and high proportion of bilateral dual-set blood cultures were associated with the reductions in both the per capita antimicrobial costs and total hospitalization expenses. Furthermore, the increase of the proportion of sterile specimen submissions was associated with the decrease of the mortality rate (all P< 0.05). CONCLUSIONS Optimizing the multi-links of etiological submission may effectively improve the quality of etiological submission from ICU patients, provide guidance for precise use of antibiotics, and reduce the medical cost. It may have positive effect on the prognosis of the patients.
下载: